Myositis in primary Sjögren's syndrome: Data from a multicentre cohort

Clinical and Experimental Rheumatology

Volumn 33, Issue 4, 2015, Pages 457-464

  Colafrancesco, Serena ^a   Priori, Roberta ^a   Gattamelata, Angelica ^a   Picarelli, Giovanna ^a   Minniti, Antonina ^a   Brancatisano, Filippo ^a   D'Amati, Giulia ^a   Giordano, Carla ^a   Cerbelli, Bruna ^a   Maset, Marta ^b   Quartuccio, Luca ^b   Bartoloni, Elena ^c   Carubbi, Francesco ^d   Cipriani, Paola ^d   Baldini, Chiara ^e   Luciano, Nicoletta ^e   De Vita, Salvatore ^b   Gerli, Roberto ^c   Giacomelli, Roberto ^d   Bombardieri, Stefano ^e   Valesini, Guido ^a   more..

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d UNIVERSITY OF L'AQUILA   (Italy)

^e UNIVERSITY OF PISA   (Italy)

Author keywords

Dermatomyositis; Histology; Inclusion body myositis; Polymyositis; Sj gren's syndrome

Indexed keywords

AZATHIOPRINE; CREATINE KINASE; CYCLOSPORIN; CYTOCHROME C OXIDASE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; METHOTREXATE; PREDNISONE; RITUXIMAB; ANTIRHEUMATIC AGENT; AUTOANTIBODY; GLUCOCORTICOID;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; ELECTROMYOGRAPHY; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY (TOPIC); MUSCLE BIOPSY; MUSCLE WEAKNESS; MYALGIA; MYOSITIS; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SJOEGREN SYNDROME; YOUNG ADULT; BIOPSY; BLOOD; CLINICAL TRIAL; COMPLICATION; ITALY; MULTICENTER STUDY; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; SKELETAL MUSCLE;

ADULT; ANTIRHEUMATIC AGENTS; AUTOANTIBODIES; BIOPSY; CREATINE KINASE; ELECTROMYOGRAPHY; ELECTRON TRANSPORT COMPLEX IV; FEMALE; GLUCOCORTICOIDS; HUMANS; ITALY; MALE; MIDDLE AGED; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MYOSITIS; PREVALENCE; RETROSPECTIVE STUDIES; SJOGREN'S SYNDROME;

EID: 84939504715     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. IANNUCCELLI C, SPINELLI FR, GUZZO MP et al.: Fatigue and widespread pain in systemic lupus erythematosus and Sjögren's syndrome: symptoms of the inflammatory disease or associated fibromyalgia?. Clin Exp Rheumatol 2012; 30: 117-21.
2. OSTUNI P, BOTSIOS C, SFRISO P et al.: Fibromyalgia in Italian patients with primary Sjögren's syndrome. Joint Bone Spine 2002; 69: 51-7.
3. PRIORI R, IANNUCCELLI C, ALESSANDRI C et al.: Fatigue in Sjögren's syndrome: relationship with fibromyalgia, clinical and biologic features. Clin Exp Rheumatol 2010; 28 (Suppl. 63): S82-6.
4. KRAUS A, CIFUENTES M, VILLA AR, JAKEZ J, REYES E, ALARCON-SEGOVIA D: Myositis in primary Sjögren's syndrome. Report of 3 cases. J Rheumatol 1994; 21: 649-5.
5. LINDVALL B, BENGTSSON A, ERNERUDH J, ERIKSSON P: Subclinical myositis is common in primary Sjögren's syndrome and is not related to muscle pain. J Rheumatol 2002; 29: 717-25.
6. VRETHEM M, LINDVALL B, HOLMGREN H, HENRIKSSON KG, LINDSTRöM F, ERNERUDH J: Neuropathy and myopathy in primary Sjögren's syndrome: neurophysiological, immunological and muscle biopsy results. Acta Neurol Scand 1990; 82: 126-31.
7. PESTRONK A: Acquired immune and inflammatory myopathies: pathologic classification. Curr Opin Rheumatol 2011; 23: 595-604.
8. DALAKAS MC: Polymyositis, dermatomyositis and inclusion body myositis. N Engl J Med 1991; 325: 1487-98.
9. HOOGENDIJK JE, AMATO AA, LECKY BR et al.: 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003 Naarden, The Netherlands. Neuromuscul Disord 2004; 14: 337-45.
10. BRONNER IM, HOOGENDIJK JE, WINTZEN AR et al.: Necrotising myopathy, an unusual presentation of a steroid-responsive myopathy. J Neurol 2003; 250: 480-5.
11. MOLINA R, PROVOST TT, ARNETT FC et al.: Primary Sjögren's syndrome in men. Clinical, serologic and immunogenetic features. Am J Med 1986; 80: 23-31.
12. RINGEL SP, FORSTOT JZ, TAN EM, WEHLING C, GRIGGS RC, BUTCHER D: Sjögren's syndrome and polymyositis or dermatomyositis. Arch Neurol 1982; 39: 157-63.
13. ALEXANDER EL: Neuromuscular complications of primary Sjögren's syndrome. In: TALAL N, MOUTSOPOULOS HM, KASSAN SS (Eds.) Sjögren's syndrome. Clinical and immunological aspects. Berlin: b. Springer Verlag; 1987: 61-82.
14. PARDOS GEA J, SELVA O'CALLAGHAN A, SANS VALETA J, GRAU JUNYENT JM: Inclusion body myositis and primary Sjögren syndrome. Med Clin (Barc). 2003; 120: 318-9.
15. MONTEIRO P, COUTINHO M, SALVADOR MJ, MALCATA A: Primary Sjögren Syndrome and inclusion body myositis. Acta Reumatol Port 2009; 34: 261-5.
16. VITALI C, BOMBARDIERI S, MOUTSOPOULOS HM et al.: Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993; 36: 340-7.
17. VITALI C, BOMBARDIERI S, JONSSON R et al.: European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-8.
18. BOHAN A, PETER JB: Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344-7.
19. PRIETO S, GRAU JM: The geoepidemiology of autoimmune muscle disease. Autoimmun Rev 2010; 9: A330-4.
20. ARBUCKLE MR, Mc CLAIN MT, RUBERTONE MV et al.: Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526-33.
21. KASUKAWA R, SHARP GC: Diagnostic criteria for classification of MCTD. In: SHARP GC (Ed.) Mixed connective tissue diseases and antinuclear antibodies. Elsevier, Amsterdam 1987; 23-32.
22. CHAD D, GOOD P, ADELMAN L, BRADLEY WG, MILLS J: Inclusion body myositis associated with Sjögren's syndrome. Arch Neurol 1982; 39: 186-8.
23. GUTMANN L, GOVINDAN S, RIGGS JE, SCHOCHET SS: Inclusion body myositis and Sjogren's syndrome. Arch Neurol 1985; 42: 1021-2.
24. KHARISHI MM, JAY V, KEYSTONE EC: Inclusion body myositis in association with vitamin B12 deficiency and Sjögren's syndrome. J Rheumatol 1992; 19: 306-9.
25. KANELLOPOULOS P, BALTOYIANNIS C, TZIOUFAS AG: Primary Sjögren's syndrome associated with inclusion body myositis. Rheumatology (Oxford) 2002; 41: 440-4.
26. KOFFMAN BM, SIVAKUMAR K, SIMONIS T, STRONCEK D, DALAKAS MC: HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies. J Neuroimmunol 1998; 84: 139-42.
27. QUARTUCCIO L, DE MARCHI G, SCOTT CA, FERRACCIOLI G, BELTRAMI CA, De VITA S: Treatment of inclusion body myositis with cyclosporin-A or tacrolimus: successful long-term management in patients with earlier active disease and concomitant autoimmune features. Clin Exp Rheumatol 2007; 25: 246-51.
28. SIEPMANN T, TESCH M, KRAUSE F, ILLIGENS BM, STOLTENBURG-DIDINGER G: Polymyo-sitis with cytochrome C oxidase negative fibres. a pathological and clinical challenge. Ann Diagn Pathol 2013; 17: 183-6.
29. BOHAN A, PETER JB, BOWMAN RL, PEARSON CM: Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977; 56: 255-86.
30. THOMPSON PD, CLARKSON P, KARAS RH: Statin-associated myopathy. JAMA 2003; 289: 1681-90.
31. MASTAGLIA FL, NEEDHAM M: Update on toxic myopathies. Curr Neurol Neurosci Rep 2012 Feb; 12: 54-61.
32. SIBILIA J, CHATELEUS E, MEYER A, GOTTENBERG JE, SORDET C, GOETZ J: How can we diagnose and better understand inflammatory myopathies?. The usefulness of auto-antibodies. Presse Med 2010; 39: 1010-25.
33. TEENER JW: Inflammatory and Toxic. Myopathy Semin Neurol 2012; 32: 491-9.
34. BADER-MEUNIER B, DECALUWE H, BAR-NERIAS C et al.; for the Club Rhumatismes et Inflammation: Safety and efficacy of rituximab in severe juvenile dermatomyositis: results from 9 patients from the French Autoimmunity and Rituximab registry. J Rheumatol 2011; 38: 1436-40.
35. MAHLEREA, BLOM M, VOERMANS NC, van ENGELEN BG, van RIEL PL, VONK MC: Rituximab treatment in patients with refractory inflammatory myopathies. Rheumatology (Oxford) 2011; 50: 2206-13.
36. DALAKAS MC: Review: An update on inflammatory and autoimmune myopathies. Neuropathology and Applied Neurobiology 2011; 37: 226-42.
37. AGGARWAL R, ODDIS CV: Therapeutic advances in myositis. Current Opin Rheumatol 2012; 24: 635-64.